# A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension

> **NCT00311389** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 408 (actual)

## Conditions studied

- Glaucoma, Open-angle
- Ocular Hypertension

## Interventions

- **DRUG:** Travoprost 0.004%/Timolol maleate 0.5% ophthalmic solution
- **DRUG:** Latanoprost 0.005%/Timolol 0.005% ophthalmic solution

## Key facts

- **NCT ID:** NCT00311389
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2004-09
- **Final completion:** 2004-09
- **Target enrollment:** 408 (ACTUAL)
- **Last updated:** 2012-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00311389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00311389, "A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00311389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*